OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT2: Controversy and multiple roles in disease and physiology
Yan Wang, Jingqi Yang, Tingting Hong, et al.
Ageing Research Reviews (2019) Vol. 55, pp. 100961-100961
Closed Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 485

Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Jin Zhang, Honggang Xiang, Jie Liu, et al.
Theranostics (2020) Vol. 10, Iss. 18, pp. 8315-8342
Open Access | Times Cited: 321

The ambiguous role of sirtuins in head and neck squamous cell carcinoma
Devaraj Ezhilarasan, Lakshmi Thangavelu, Subha Manoharan, et al.
Oral Diseases (2021) Vol. 28, Iss. 3, pp. 559-567
Closed Access | Times Cited: 116

SIRT2 regulates extracellular vesicle-mediated liver–bone communication
Longshuai Lin, Zengya Guo, Enjun He, et al.
Nature Metabolism (2023) Vol. 5, Iss. 5, pp. 821-841
Open Access | Times Cited: 43

Advances in targeting histone deacetylase for treatment of solid tumors
Mu-Qi Shi, Ying Xu, Xin Fu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 25

Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7

Sirtuins' control of autophagy and mitophagy in cancer
Michele Aventaggiato, Enza Vernucci, Federica Barreca, et al.
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107748-107748
Closed Access | Times Cited: 88

Celastrol exerts anti‐inflammatory effect in liver fibrosis via activation of AMPK‐SIRT3 signalling
Yuqin Wang, Minjing Li, Jingya Gu, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 941-953
Open Access | Times Cited: 82

Restoring nuclear entry of Sirtuin 2 in oligodendrocyte progenitor cells promotes remyelination during ageing
Xiao-Ru Ma, Xudong Zhu, Yujie Xiao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 53

Sirtuin Modulators: Past, Present, and Future Perspectives
Francesco Fiorentino, Nicola Mautone, Martina Menna, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 12, pp. 915-939
Open Access | Times Cited: 39

Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice
Yang Zhang, Xiaoman Wang, Xun-Kai Li, et al.
European Heart Journal (2023) Vol. 44, Iss. 29, pp. 2746-2759
Open Access | Times Cited: 33

Deacetylation of Septin4 by SIRT2 (Silent Mating Type Information Regulation 2 Homolog-2) Mitigates Damaging of Hypertensive Nephropathy
Ying Zhang, Naijin Zhang, Yuanming Zou, et al.
Circulation Research (2023) Vol. 132, Iss. 5, pp. 601-624
Open Access | Times Cited: 28

SIRT2 counteracts primate cardiac aging via deacetylation of STAT3 that silences CDKN2B
Yanxia Ye, Kuan Yang, Haisong Liu, et al.
Nature Aging (2023) Vol. 3, Iss. 10, pp. 1269-1287
Closed Access | Times Cited: 28

The dual role of sirtuins in cancer: biological functions and implications
Lu Yu, Yanjiao Li, Siyuan Song, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11

Immunometabolism in cancer: basic mechanisms and new targeting strategy
Ranran Su, Yingying Shao, Manru Huang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10

Targeting sirtuins for cancer therapy: epigenetics modifications and beyond
Hui Shen, Xinyi Qi, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 17, pp. 6726-6767
Open Access | Times Cited: 8

SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer’s disease
Mridula Bhalla, Jinhyeong Joo, Daeun Kim, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1

Resilience in adversity: Exploring Adaptive Changes in Cancer Cells Under Stress
Taissa dos Santos Uchiya, Helena Napoli da Cunha, Matheus Correia Casotti, et al.
Tissue and Cell (2025) Vol. 93, pp. 102756-102756
Closed Access | Times Cited: 1

Admission glucose, HbA1c levels and inflammatory cytokines in patients with acute ST-elevation myocardial infarction
Meisinger Christa, Freuer Dennis, Richard Philip, et al.
Clinical Proteomics (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1

The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?
Lin Zhang, Sungjune Kim, Xiubao Ren
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 59

Neuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics
Lorenzo Gaetani, G. Bellomo, Lucilla Parnetti, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1930-1930
Open Access | Times Cited: 51

Characterization of Histone Deacetylase Mechanisms in Cancer Development
Rihan Hai, Liuer He, Guang Shu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47

Sirtuin 2 Regulates Protein LactoylLys Modifications
Erin Q. Jennings, Jason D. Ray, Christopher J. Zerio, et al.
ChemBioChem (2021) Vol. 22, Iss. 12, pp. 2102-2106
Open Access | Times Cited: 44

SIRT2-mediated deacetylation and deubiquitination of C/EBPβ prevents ethanol-induced liver injury
Yingting Zhang, Xi‐Dai Long, Xin Ruan, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 41

Page 1 - Next Page

Scroll to top